4//SEC Filing
Parini Michael 4
Accession 0001209191-21-014736
CIK 0000875320other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:18 PM ET
Size
12.1 KB
Accession
0001209191-21-014736
Insider Transaction Report
Form 4
Parini Michael
EVP & CLO
Transactions
- Tax Payment
Common Stock
2021-02-24$217.57/sh−2,416$525,649→ 33,865 total - Sale
Common Stock
2021-02-25$211.58/sh−646$136,681→ 33,219 total - Sale
Common Stock
2021-02-25$213.04/sh−1,348$287,178→ 31,871 total - Sale
Common Stock
2021-02-25$214.28/sh−680$145,710→ 31,191 total - Sale
Common Stock
2021-02-25$216.26/sh−354$76,556→ 30,837 total
Footnotes (6)
- [F1]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91).
- [F3]Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $213.04 (range $212.76 to $213.68).
- [F5]Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69).
- [F6]Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001661567
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:18 PM ET
- Size
- 12.1 KB